CS Paper Radar

ECG2Gene: Deep Learning-Based Germline Tumor Susceptibility Gene Risk Assessment Using Electrocardiograms

Shanwei Zhang, Qinghao Zhao, Yize Zhao, Jun Li, Yongchao Long, Jinshuai Gu, Ling Yang, Huaidong Du, Yiping Chen, Zhengming Chen, Dianjianyi Sun, Jun Lv, Liming Li, Iona Y. Millwood, Robin G. Walters, Canqing Yu, Yuxi Zhou, Shenyong Chen, Shenda Hong

cs.LG ·submitted 2026-10-31 04:17 UTC · v1

Abstract

Electrocardiograms (ECGs) may contain physiological information related to hereditary cancer susceptibility, but its relationship with future cancer risk remains unclear. Here, we present ECG2Gene, a two-stage deep-learning framework that derives digital phenotypes related to germline tumor susceptibility from routine 12-lead ECGs and predicts future cancer risk. In Stage 1, carrier status for pathogenic or likely pathogenic variants in ATM, BRIP1, CHEK2, PALB2, BRCA1, and BRCA2 supervises a multitask model that generates six continuous ECG-derived gene scores. In Stage 2, XGBoost integrates these scores with clinical variables to predict subsequent breast and ovarian cancer in women and prostate cancer in men. We also introduce ECG-Wide Association Analysis (EWAS) to characterize associations between ECG-derived gene scores and ECG waveforms. Across the clinical feature combinations evaluated in UK Biobank, the best-performing sex-specific models achieve AUROCs of 0.683, 0.633, and 0.660 for breast, ovarian, and prostate cancer, respectively. In external evaluations, models combining ECG-derived gene scores with age achieve prostate cancer AUROCs of 0.709 and 0.579 among men in the overall China Kadoorie Biobank and MIMIC-IV-ECG cohorts, respectively. ECG2Gene links genetically supervised ECG phenotyping and waveform association analysis to future cancer outcomes, demonstrating the potential of routine ECGs combined with clinical information for non-invasive, opportunistic cancer risk assessment.

Closest papers

Nearest neighbours by meaning across the whole index.

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

cs.AI ·2026-10-02 ·Jungkyu Park, Dhruva Biswas, Joseph Cappadona, Cerise Tang, Ken G. Zeng +20 more
similarity 0.60
Abstract

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.

0.06

Enhancing Atrial Fibrillation Detection Through Hyperparameter Optimization

cs.LG ·2026-10-29 ·Sara Gjorgjieva, Ilinka Ivanoska, Marjan Gusev
publishedhot direction similarity 0.58
Abstract · 11 pages, 3 figures, 6 tables. Presented at the ICT Innovation 2025 Conference, Ohrid, North Macedonia. Accepted for publish by Springer in …

This study explores the role of hyperparameter optimization (HPO) in enhancing the detection of Atrial Fibrillation (AF) using both machine learning and deep learning models. We evaluated a range of standard classifiers - Decision Tree, Random Forest, and XGBoost classifiers, alongside deep learning architectures including Recurrent Neural Networks, Deep Neural Networks, and Siamese Neural Networks. To fine-tune these models, we applied four HPO methods: Genetic Algorithm, Hyperband, Optuna, and SMAC3. The experiments were conducted using inter-patient and intra- patient data splits to assess model generalization and robustness in the presence of class imbalance, which is reflective of real-world AF occurrence. Our results, based on PhysioNet electrocardiogram datasets, showed that the Hyperband-optimized XGBoost model outperformed all others, achieving a peak F1 score of 96.95%. These findings highlight the critical role of suitable HPO strategies in enhancing the accuracy and robustness of AF classification outcomes in clinical settings.

0.39

Potential of Artificial Intelligence Algorithms for Identification of Relevant Diagnostic and Prognostic Biomarkers of Early-Stage Liver Cancer

cs.AI ·2026-09-14 ·Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba +2 more
hot direction similarity 0.58
Abstract · 25 pages, 11 figures, 4 tables, under review

This study explores the use of deep learning and explainable artificial intelligence to diagnose hepatocellular carcinoma (HCC) and define effective biomarkers across five different stages of disease development using a transcriptomic biomarker HCC dataset constructed via semi-supervised learning from three source datasets. Several deep learning experiments were conducted with different feature extraction techniques and gene sets to identify the most effective features for training high-accuracy models with minimal loss. The best-performing model, using 15 selected genes with the SelectKBest algorithm, achieved 90.74% accuracy, while the model with the lowest recorded loss of 0.3187 was obtained using 20 selected genes. To address the issue of class imbalance in the dataset, a weighted training approach was conducted, and for model transparency and interpretability a SHAP-based XAI analysis provided insights into the model's decision-making, consistently finding DNAJB14 as the most influential gene. Functional validation in this study has provided compelling evidence that DNAJB14 plays an important role in the adverse properties of HCC and that its inhibition effectively reverses tumour cell migration, invasion, colony and sphere formation. The main limitation of this study is the dataset's class imbalance, and while weighted training helped mitigate this, further research and additional data are needed to guarantee model generalizability. Future studies should also explore the influence of genetic variations, environmental factors, and clinical differences on model performance across diverse populations.

0.34

Interpretable Stress Detection from ECG Signals Using Motif-Based Anomaly Analysis

eess.SP cs.LG ·2026-08-27 ·Zhanna Balyan, Sachin Kumar
similarity 0.58
Abstract

Stress detection using physiological signals has gained significant attention due to its impact on both physical and mental health. While existing approaches based on machine learning and deep learning achieve strong predictive performance, they often rely on black-box models and fail to capture individual variability in physiological responses. In this work, we propose an interpretable and personalized framework for stress detection using electrocardiogram (ECG) signals based on motif discovery and Matrix Profile analysis. Instead of training a classifier, the method learns subject-specific baseline cardiac behavior by extracting recurring heartbeat patterns (motifs) from ECG signals. Stress is then detected as a deviation from these baseline patterns using a distance-based anomaly score. Experiments are conducted on the WESAD dataset using a carefully designed train-validation-test protocol to ensure reliable evaluation. The results show that the proposed approach can effectively detect stress for several subjects while providing clear interpretability through direct comparison of ECG patterns. However, the performance varies across individuals due to differences in physiological responses, with some subjects exhibiting minimal morphological changes under stress. Additional analysis incorporating heart rate variability (HRV) features reveals that while HRV can improve performance in certain cases, its contribution is not consistent across all subjects. These findings highlight the importance of personalization and interpretability in physiological stress detection and demonstrate that motif-based approaches provide a meaningful alternative to black-box models, while also revealing inherent limitations due to inter-subject variability.

0.23

Semi-Supervised Learning-Based Genetic Biomarkers Dataset for Multiple-Stage Hepatocellular Carcinoma Prediction

cs.AI ·2026-09-15 ·Ahmed Ammar Kubba, Manar Abu Talib, Jibran Sualeh Muhammad, Ali Bou Nassif, Abdalla Sayed Mohamed +2 more
published similarity 0.58
Abstract · 6 pages, 7 figures, 2 tables, published at the 18th International Conference Series on Developments in eSystems Engineering

Liver cancer is a complex disease responsible for a high number of deaths across the globe each year, making automated solutions for liver cancer classification urgent. The most common form of liver cancer is hepatocellular carcinoma (HCC), accounting for over 90% of liver cancer cases. There is a distinct lack of publicly available HCC datasets utilizing genomic data, which is necessary for training artificial intelligence (AI) models for automated HCC classification. This study proposes constructing a multi-stage HCC dataset using XGBoost and Semi-Supervised learning on three separate datasets of genomic biomarkers, utilizing their existing labels in the Semi-Supervised learning process to label the proposed dataset. The proposed dataset consists of 770 patient samples in total, categorized into five classes that represent normal tissue alongside different stages of HCC. Each sample in the dataset consists of 11,150 different gene expression levels. The XGBoost model demonstrated a final classification accuracy of 96.5% during the Semi-Supervised learning process.

0.29

Label-Efficient Deep Learning for ECG Delineation: A Multi-Dataset Benchmark against Widely Used Delineation Tools

cs.LG cs.AIcs.CVeess.SP ·2026-10-06 ·Jeonghwa Lim, Minje Park, Yeongyeon Na, Yujin Eom, Soyeon Lim +4 more
benchmarkcode/data similarity 0.58
Abstract · 20 pages, 5 figures. First two authors contributed equally

Electrocardiogram (ECG) delineation, the identification of waveform boundaries, is a foundational step that translates raw ECG signals into clinically interpretable measurements. Deep learning has advanced this task but remains dependent on costly expert annotations. Label-efficient strategies such as self-supervised pretraining and semi-supervised learning are expected to ease this burden, yet it remains unclear whether they yield reliable delineation and whether the deep models they produce outperform the delineation tools used in practice. We address this in two stages. First, comparing self-supervised objectives with supervised or semi-supervised fine-tuning across one internal and four external datasets, we find that pretraining helps but the objective matters, and that the value of semi-supervised fine-tuning depends on the pretraining objective. Second, we benchmark the selected deep learning model against widely used open-source (NeuroKit2, Prominence, ECGdeli) and commercial (CalECG) tools using three complementary metrics. The model ranks best on every metric and dataset, outperforming the strongest tool by a clear margin on the rhythm-diverse set (mIoU 71.3 vs. 54.8%; averaged point-wise sensitivity 92.6 vs. 76.4%), and degrades the least from sinus to arrhythmia. A rhythm-stratified and point-wise analysis further characterizes the distinctive behavior of each tool, yielding practical guidance for tool selection. These results provide systematic, multi-dataset evidence that self-supervised pretraining is effective for ECG delineation and enables a label-efficiently trained deep learning model to outperform widely used delineation tools by leveraging abundant unlabeled data. This supports adopting such models in diverse, real-world clinical settings.

0.30

Deep Learning-Based Prediction of HER2 Status from Whole-Brain MRI in Breast Cancer Brain Metastases

cs.LG ·2026-10-23 ·Sara Early, Chris Kang, Vibujithan Vigneshwaran, Kimberly Amador, Roger Y. Tsang +1 more
similarity 0.57
Abstract

Purpose: Human epidermal growth factor receptor 2 (HER2) status is a key biomarker relevant for prognostication and treatment decision making in metastatic breast cancer. Thus, the aim of this work was to explore whether HER2 status can be predicted directly from whole-brain post-contrast T1-weighted (T1w) MRI scans in breast cancer brain metastases (BCBM) using deep learning, and whether providing explicit tumour segmentation information improves prediction. Methods: Using the publicly available BCBM-Radiogenomics dataset, we analysed 135 patients, including 70 HER2+ and 65 HER2- patients. Three approaches were implemented and evaluated: a conventional radiomics model, a simple fully convolutional network (SFCN) using T1w MRI scans alone, and an SFCN using T1w MRI scans with an expert-derived tumour mask as an additional input channel. Results: The radiomics model achieved an area under the receiver operating characteristic curve (ROC-AUC) of 0.602 (95% confidence interval [CI]: 0.528--0.677) while the SFCN achieved a ROC-AUC of 0.667 (95% CI, 0.63--0.71) using T1w MRI scans alone, which increased to 0.692 (95% CI, 0.58--0.81) when an explicit tumour mask was additionally provided. Conclusion: However, the modest performance across all approaches demonstrates the difficulty of predicting HER2 status from structural MRI scans alone. The difference between the segmentation-free and mask-guided SFCN models suggests that much of the predictive signal captured by the deep-learning model may be learned directly from whole-brain T1w MRI without requiring explicit tumour delineation. These findings support further investigation of segmentation-free deep-learning approaches as a potential non-invasive strategy to support HER2 status determination in BCBM.

0.19

Deviation-Aware Pretraining for Cardiovascular Disease Detection from Electrocardiograms

cs.LG ·2026-11-10 ·Siyuan Yan, Haibo Zheng, Feng Lu, Wei Li
similarity 0.57
Abstract

Electrocardiogram (ECG) signals are critical for cardiovascular disease (CVD) detection. Most current deep learning models rely on supervised, task-specific training, which limits their ability to generalize across diseases, patient populations, and acquisition settings. This paper presents a self-supervised ECG feature extraction framework that learns from nearly one million unlabeled 12-lead ECG recordings. The framework includes two modules: Deviation Localization Embedding (DLE), which detects waveform-level deviations from normal patterns, and Association Reconstruction Embedding (ARE), which models cross-lead associations through deviation-guided reconstruction to capture abnormal patterns expressed across multiple leads. These modules enable the framework to capture subtle deviation-related patterns and their cross-lead context. The framework achieves up to 6.5% AUROC and 12.8% F1 improvements over prior methods on multiple public datasets, even without additional fine-tuning the pretrained feature extractor. Embedding visualizations show that the learned features support meaningful disease grouping and anomaly identification. The approach reduces the need for labeled data and can support clinicians in diverse healthcare settings. The framework has potential to improve early detection and monitoring of cardiovascular diseases, contributing to more accessible and equitable heart care.

0.20